Compounds > 5-aza-2'-deoxycytidine-5'-triphosphate
Page last updated: 2024-09-03

5-aza-2'-deoxycytidine-5'-triphosphate and cytarabine

5-aza-2'-deoxycytidine-5'-triphosphate has been researched along with cytarabine in 1 studies

Compound Research Comparison

Studies
(5-aza-2'-deoxycytidine-5'-triphosphate)		Trials
(5-aza-2'-deoxycytidine-5'-triphosphate)		Recent Studies (post-2010)
(5-aza-2'-deoxycytidine-5'-triphosphate)		Studies
(cytarabine)		Trials
(cytarabine)		Recent Studies (post-2010) (cytarabine)
2401215,4872,4243,188

Protein Interaction Comparison

ProteinTaxonomy5-aza-2'-deoxycytidine-5'-triphosphate (IC50)cytarabine (IC50)
nuclear receptor coactivator 3 isoform aHomo sapiens (human)7.533
E3 ubiquitin-protein ligase Mdm2Homo sapiens (human)0.02

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Attadia, V; Cimino, R; Maio, M; Pinto, A; Zappacosta, S1

Other Studies

1 other study(ies) available for 5-aza-2'-deoxycytidine-5'-triphosphate and cytarabine

ArticleYear
Modulation of HLA-DR antigens expression in human myeloid leukaemia cells by cytarabine and 5-aza-2'-deoxycytidine.
    Lancet (London, England), 1984, Oct-13, Volume: 2, Issue:8407

    Topics: Azacitidine; Cells, Cultured; Cytarabine; Cytidine Triphosphate; Cytosine Nucleotides; Gene Expression Regulation; Histocompatibility Antigens Class II; HLA-DR Antigens; Humans; Leukemia, Myeloid, Acute

1984